Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.
The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.
Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives.
The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Infinium Pharmachem IPO Details
| Total Issue Size | 1,875,000 shares
(aggregating up to ₹25.31 Cr) |
| Fresh Issue | 1,875,000 shares
(aggregating up to ₹25.31 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
Infinium Pharmachem IPO Reservation
| Market Maker portion | 94,000 shares (SWASTIKA INVESTMART LIMITED) |
Company Financials
Infinium Pharmachem Private Limited Financial Information (Restated Consolidated)| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|
| 31-Mar-20 | 2,244.60 | 3,941.64 | 93.40 | 424.74 | 566.17 |
| 31-Mar-21 | 3,418.27 | 7,115.37 | 272.48 | 702.32 | 579.47 |
| 31-Mar-22 | 5,899.95 | 10,005.25 | 610.64 | 1,310.22 | 1,385.01 |
| 30-Sep-22 | 7,075.71 | 7,985.39 | 551.01 | 1,855.77 | 1,614.71 |
| Amount in ₹ Lakhs |
Strength
Weakness
